📊 Score Breakdown
Offering Ability
20
Cash Runway
40
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 7 points (worsening)
💹 Market Data
Market Cap$39.35M
Shares Outstanding11.71M
Float4.86M
Cash$4.29M
Debt$118.0K
Short InterestN/A
🏛 Institutional Holdings
2 institutional holders · 2.4K shares
#1
Morgan Stanley
2.0K shares
#2
UBS Group AG
378 shares
📉 Short Interest
Short Interest155.0K
Days to Cover2.1
% of Float3.4%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NSRX
📊 NSRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NSRX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.